The Full Story
About Us
Founded in 2024 by Mayur Talele, with Kishan Patel as CTO, Antigence is a pioneering technology company at the forefront of AI and biologic therapeutics. Our mission is to transform the landscape of synthetic biology by providing researchers with innovative solutions that accelerate the discovery and development of antibody structures. Leveraging our cutting-edge generative AI platform, we empower scientists to create optimized antibody designs tailored for specific proteins and viruses, significantly enhancing research efficiency and precision. At Antigence, we are committed to bridging the gap between computational biology and practical application, driving scientific advancements that have the potential to revolutionize the field of therapeutics.
Mayur Talele
Founder & CEO
Mayur leads Antigence with a vision to revolutionize antibody therapeutics using AI. As a biochemistry researcher, he identified a critical need for innovative tools in therapeutic development. Mayur has spearheaded Antigence’s mission from concept to execution, overseeing the development of the company’s generative AI platform and building key partnerships with academic and industry researchers. His deep passion for the design and development of therapeutics has been pivotal in guiding the development of Antigence’s technology.
Kishan Patel
CTO
Kishan drives the technological vision at Antigence, leading the development of the company’s cutting-edge AI/ML platform. As CTO, he oversees the design and optimization of Antigence’s proprietary algorithms, ensuring seamless functionality for antibody prediction and design. As a biology researcher, he understands the demand for a high-powered AI tool. Kishan’s passion for innovation and technology has been instrumental in building Antigence’s platform to empower researchers with advanced solutions in antibody therapeutics.
